Shin Nippon Biomedical Laboratories, Ltd.

2395.T
Diagnostics & Research
2026/01/16 Updated
Market Cap: $436.6M (¥69.2B)
Stock Price: $10.49 (¥1,662)
Exchange Rate: 1 USD = ¥158.48

Stock Price Chart

2026/01/16 Updated
14.86
PER (Price Earnings Ratio)
vs Industry Avg: +5.3
1.83
PBR (Price to Book Ratio)
vs Industry Avg: +0.5
3.01%
Dividend Yield
vs Industry Avg: +0.06%

Price Trend

2026/01/16 Updated
Short-term
5-Day MA
+1.45%
Near-term
25-Day MA
-5.97%
Mid-term
75-Day MA
-0.69%
Long-term
200-Day MA
+9.72%

Price & Trading Details

2026/01/16 Updated

PRICE

Previous Close ¥1,624
Open ¥1,620
High ¥1,667
Low ¥1,619
Close ¥1,662

TRADING

Volume 246,100
Average Volume 281,311
Turnover ¥4億
Min. Purchase ¥166,200

Dividend History

Updated 2026/01/11
-%
Dividend Yield
¥50
Annual Dividend
0.0%
YoY Growth
42.3%
Payout Ratio
Year Dividend Change
2025 ¥50 0.0%
2024 ¥50 0.0%
2023 ¥50 -16.7%
2022 ¥60 +300.0%
2021 ¥15 -

Financial Performance

2026/01/11 Updated

No financial data available

Latest IR Information

  • No IR information found for this company.

    Searched stock code: 2395

Latest News (5 items)

Company Information

English Name Shin Nippon Biomedical Laboratories, Ltd.
Japanese Name (株)新日本科学
Stock Code 2395.T (JPX)
Sector / Industry Healthcare / Diagnostics & Research
Website https://www.snbl.co.jp
Employees 1,531

About

Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally. It offers non-clinical testing and non-clinical regulatory consulting for the development of pharmaceuticals, medical devices, or regenerative medicine products, including safety and pharmacology testing, and pharmacokinetic studies. The company also engages in licensing activities for proprietary products which utilize unique intranasal formulation delivery technology, discovery of future seeds, and business promotion activities; and development of artificial seed production for Japanese eels. In addition, it operates hotels accommodations facilities under the Villa Amafuru Oka and HOTEL Freesia names; and develops and operates geothermal and hot spring thermal power plants. Shin Nippon Biomedical Laboratories, Ltd. was founded in 1957 and is headquartered in Kagoshima, Japan.

Data provided by Yahoo Finance